ライフサイエンスコーパス: HIV status

1 7% female; 32% HIV-infected, and 32% unknown HIV status).

2 d tumor cell PD-L1 expression, regardless of HIV status.

3 ates to determine differences by frailty and HIV status.

4 his relationship held when we controlled for HIV status.

5 treatment, age (0-4 years, 5-14 years), and HIV status.

6 robiota and persistent hrHPV was modified by HIV status.

7 fy high-risk youths who are unaware of their HIV status.

8 d tested for antiretroviral drugs to confirm HIV status.

9 assessing organ donor risk, irrespective of HIV status.

10 lockade in anal SCC, irrespective of patient HIV status.

11 d according to an individual's self-reported HIV status.

12 d by additional information on self-reported HIV status.

13 nce of obstructive disease did not differ by HIV status.

14 xposure questionnaires, and an assessment of HIV status.

15 mbination antiretroviral therapy (cART), and HIV status.

16 in the absence of documentation of positive HIV status.

17 5.2) of these individuals already knew their HIV status.

18 the NP examiner was blinded to screening and HIV status.

19 ell tolerated and active in KS regardless of HIV status.

20 cted people in sub-Saharan Africa know their HIV status.

21 The analysis was stratified according to HIV status.

22 rsion and reversion were not associated with HIV status.

23 s specific disease or diseases stratified by HIV status.

24 5% CI, -.30 to .10] years) did not differ by HIV status.

25 minates were rare (0.2%) and not affected by HIV status.

26 an be impacted by population factors such as HIV status.

27 mulative incidence and hazard rates, each by HIV status.

28 cular inflammation (28 eyes), independent of HIV status.

29 tudy evaluating MI risk from 1996 to 2011 by HIV status.

30 a were further stratified by risk factor and HIV status.

31 globulin G (IgG) to VSA were not affected by HIV status.

32 h XDR tuberculosis are poor, irrespective of HIV status.

33 between elevated BP and AMI risk differs by HIV status.

34 ults, and has high mortality irrespective of HIV status.

35 orne infections, independent of their HCV or HIV status.

36 gle clinicopathological entity regardless of HIV status.

37 d disease outcome were compared according to HIV status.

38 t of syphilis according to disease stage and HIV status.

39 mined the association of these variants with HIV status.

40 S on multivariate analysis including IPS and HIV status.

41 younger age at treatment start, and negative HIV status.

42 100-child-years in relation to time-updated HIV status.

43 pulation expectations, but did not differ by HIV status.

44 was not significantly affected by enrollment HIV status.

45 ld not be withheld or deintensified based on HIV status.

46 Participants self-reported HIV status.

47 Patients age 55 to 75 years with unknown HIV status.

48 nge in HIV Infection), stratified by sex and HIV status.

49 % CI, 41% to 69%; P < .001), irrespective of HIV status.

50 s, adjusted for study site, risk cohort, and HIV status.

51 itamin A, selenium, and zinc irrespective of HIV status.

52 a-tocopherol did not differ significantly by HIV status.

53 alculated each year by demographic group and HIV status.

54 different for PenG and APPG-P, regardless of HIV status.

55 re 46% and 98%, respectively, and similar by HIV status.

56 l illness across age groups, irrespective of HIV status.

57 response, and severity of cirrhosis, but not HIV status.

58 justing for sex, age, sputum microscopy, and HIV status.

59 ed to assess the independent contribution of HIV status.

60 o stratify anal cancer risk, irrespective of HIV status.

61 plasia (CIN) grade 2 or higher regardless of HIV status.

62 fy current and future NCD burden in Kenya by HIV status.

63 as well as cumulative incidence of death by HIV status.

64 oncontrast abdominal CT was not different by HIV status.

65 iated with greater severity of steatosis, by HIV status.

66 ion by diarrhea at admission, age, edema, or HIV status.

67 different for PenG and APPG-P, regardless of HIV status.

68 en in Kenya by human immunodeficiency virus (HIV) status.

69 men with known human immunodeficiency virus (HIV) status, 15% of those without measles and 19% of tho

70 HIV and (1) maternal orphanhood and maternal HIV status, (2) reported sexual behaviour, and (3) repor

71 Among those who knew their HIV status, 2617 (87.4%, 95% CI 85.8-89.0) were receivin

72 dividuals gained knowledge of their positive HIV status, 2818 were linked to care, 2151 became eligib

73 ing with HIV (6.96, 5.46-8.89) or of unknown HIV status (3.08, 2.50-3.81); gestational age of less th

74 Among living patients, 82% knew their HIV status, 45% were linked to care, 39% were eligible f

75 morbidities (41.8%), ASA status (11.3%), and HIV status (7.8%), with a smaller proportion stratifying

76 individuals living with HIV will know their HIV status, 90% of people with diagnosed HIV infection w

77 3 +/- 1.7 nmol/L; n = 121) subjects, nor was HIV status a significant predictor of plasma 25(OH)D whe

78 opART) trial sought to increase knowledge of HIV status across all groups by offering the choice of o

79 ence in pneumococcal acquisition by maternal HIV status (adjusted rate ratio (aRR) = 1.00, 95% confid

80 of T-cell subsets and diabetes stratified by HIV status, adjusted for cytomegalovirus serostatus and

81 ciations between inflammatory biomarkers and HIV status, adjusting for CVD risk factors.

82 ts), site, and human immunodeficiency virus (HIV) status (adults only) were calculated using modified

83 tion, 80% of men and 85% of women knew their HIV status after the CHiP visit.

84 e proportions of participants who knew their HIV status after the CHiP visit; proportions linking to

85 a partner in the past 6 months with unknown HIV status (aHR 2.87, 1.44-5.84, p=0.0030).

86 No conclusive evidence showed that HIV status altered treatment efficacy.

87 with SAM are treated similarly regardless of HIV status, although mechanisms of nutritional recovery

88 NCD burden was quantified for 2018-2035 by HIV status among adults.

89 s and seek new ways to increase awareness of HIV status among men and promote couples testing.

90 NCD burden was quantified for 2018-2035 by HIV status amongst adults.

91 Analyses were stratified by sex and HIV status and adjusted for demographic, lifestyle, and

92 need for assumptions concerning knowledge of HIV status and ART coverage among adults not consenting

93 communities in BAL differed significantly by HIV status and by COPD, with Pneumocystis jirovecii sign

94 c regression to examine associations between HIV status and cancer treatment, adjusted for cancer sta

95 We assessed the HIV status and CD4 counts of index patients, as well as

96 HIV status and change in aspartate aminotrasferase-to-pl

97 In multivariable analysis, controlling for HIV status and continent of origin, people from Africa h

98 No association between HIV status and cytokine concentrations was found.

99 gression to describe the association between HIV status and day-28 mortality, after separate adjustme

100 n to examine the association between patient HIV status and death resulting from the presenting cance

101 ght the importance of improving awareness of HIV status and expanding ART to prevent losses in HRQoL

102 For the Stroop portions, HIV status and HIV x push-ups were significant predictor

103 infant pneumococcal acquisition by maternal HIV status and household exposure in Karonga District, M

104 sites we collected additional data including HIV status and in-hospital outcome.

105 The prevalence is high regardless of HIV status and is high even in those who did not undergo

106 Examine the impact of HIV status and level of immunosuppression on the distrib

107 no relationship between treatment regimen or HIV status and likelihood of normalization of any measur

108 HEV data were correlated with HIV status and morphometric analysis of small intestinal

109 mixed patterns of transmission regardless of HIV status and no overlap with the general population.

110 HIV status and partum status did not show any significan

111 HIV status and pneumococcal culture positivity in the CS

112 d metastats to compare fungal communities by HIV status and presence of COPD.

113 justed for age and gender, and stratified by HIV status and previous tuberculosis-treatment history.

114 graphics, medical history and comorbidities, HIV status and related measures (CD4 cell counts, HIV vi

115 c HALE was estimated from 20 years of age by HIV status and sex.

116 egression to assess the relationship between HIV status and standard treatment modality.

117 Children were recruited irrespective of HIV status and started on a standard antimicrobial regim

118 resulted in significant interactions between HIV status and time of study in left insula, left pariet

119 Patients were stratified by HIV status and tuberculosis drug resistance.

120 adult Burkitt lymphoma regardless of age or HIV status and was well tolerated.

121 useholds had at least one child with unknown HIV status and were enrolled into the trial.

122 talized SRI by human immunodeficiency virus (HIV) status and compared children who tested positive fo

123 ent regimen or human immunodeficiency virus (HIV) status and likelihood of normalization of any measu

124 the impact of human immunodeficiency virus (HIV) status and type on the clearance of HPV infection a

125 studies should clarify the relation between HIV-status and GBS carriage.

126 life (including mother's age at delivery and HIV status) and current life factors (including maternal

127 IV in adults, with neonates (irrespective of HIV status), and with Salmonella Typhimurium ST313.

128 7.2%] of 3165 women with partners of unknown HIV status, and 696 [11.6%] of 5997 women with HIV-negat

129 ts were not uniformly performed according to HIV status, and adequate fasting before lipoprotein test

130 Independent effects of sex, HIV status, and aging on immune activation may contribut

131 In adults it is strongly associated with HIV status, and also with environmental enteropathy.

132 women and 85% of HIV-positive men knew their HIV status, and among these individuals, approximately 9

133 Vitamins with information on infant feeding, HIV status, and at least one visit in the first year wer

134 atio 3.90, p<0.001) after adjusting for age, HIV status, and condom use.

135 Adult index characteristics such as sex, HIV status, and extent or severity of disease were not a

136 ings support the need for HCWs to know their HIV status, and for HIV-infected HCWs to be offered anti

137 Time period, HIV status, and genetic relatedness (ie, cluster status)

138 Four controls, matched for age, HIV status, and hospital were sought for each case.

139 apy was equally effective across age groups, HIV status, and International Prognostic Index risk grou

140 CT prophylaxis compliance, non-disclosure of HIV status, and non-Sukuma ethnicity.

141 broader effort that encompassed minimum age, HIV status, and organ dysfunction.

142 We intended to stratify the analyses by age, HIV status, and rural or urban setting; however, few stu

143 le linear regression, adjusted for age, sex, HIV status, and socioeconomic status.

144 Questionnaire data, HIV status, and standard spirometry were obtained from 1

145 al controls for every case, matched for age, HIV status, and study site.

146 than one-third (34%) had partners of unknown HIV status, and the vast majority (n = 1,200 [94%]) repo

147 he association between inflammatory markers, HIV status, and traditional CVD risk factors.

148 ars, were negative for HIV or had an unknown HIV status, and were TBI positive.

149 en, compared according to sexual preference, HIV status, and, when available, anal cytopathology.

150 xual behavior, human immunodeficiency virus (HIV) status, and vaccinations.

151 Analyses were stratified by maternal HIV-status, and incidence computed per 1,000 person-mont

152 Independent of HIV status, anemia was present in 23.4% and 8% in blacks

153 nt when adjusted for HIV status of partner), HIV status (aOR 11.22, 4.05-31.05), lack of viral load s

154 expand HIV testing and support disclosure of HIV status are needed.

155 acterial DNA in blood were low regardless of HIV status, ART status, and immune activation status.

156 death was ascertained via verbal autopsy and HIV status at delivery via annual HIV surveys.

157 58 were HIV-negative, and 15,994 had unknown HIV status at delivery.

158 r delivery were included if they had unknown HIV status at presentation (there was no age limit for t

159 HIV status aware couples with at least one HIV positive

160 at elevated partnership dissolution rates in HIV status aware serodiscordant couples reduce the sprea

161 vior changes (e.g., increased condom use) in HIV status aware serodiscordant partnerships.

162 o account, each percentage point increase in HIV status awareness reduces HIV incidence by 0.13 and 0

163 solution, every percentage point increase in HIV status awareness reduces HIV incidence in monogamous

164 ovements in HIV testing among MSM in Africa, HIV status awareness, ART coverage, and viral suppressio

165 ot receiving these at presentation; or known HIV status but had never received treatment.

166 nicillin for early syphilis, irrespective of HIV status, but data from coinfected patients are limite

167 Patients did not differ significantly by HIV status by age, sex, or race/ethnicity due to the mat

168 Uganda, to evaluate the association between HIV status, CD4 cell count, and other clinical predictor

169 We compared anal high-risk HPV prevalence by HIV status, cervical high-risk HPV, cervical cytohistopa

170 lly the LMX1A-AA carriers (LMX1A genotype by HIV status, cluster-corrected-p < 0.0001).

171 the HIV self-testing group had knowledge of HIV status compared with 8952 (65%) of 13 706 in the non

172 2007-2009, 1,777 pregnant women with unknown HIV status completed an interviewer-administered questio

173 rimoxazole until breastfeeding cessation and HIV-status confirmation.

174 for confounding variables including contact HIV status, contact age, socio-economic status, and inde

175 The adjusted MI rate ratio for HIV status declined over time, reaching 1.0 (95% confide

176 The primary outcome was knowledge of HIV status (defined as self-reporting HIV positive to th

177 HIV status did not affect the area under the curve (AUC(

178 While HIV status did not affect the likelihood of being an inf

179 HIV status did not predict OS or EFS on multivariate ana

180 l with near-perfect ART adherence and mutual HIV status disclosure among all participating couples.

181 wash samples of HIV-negative sex workers and HIV-status discordant couples.

182 le-blood glutathione, and whole-blood GPX to HIV status, disease severity, immune activation, and oxi

183 emopoietic cell transplantation suggest that HIV status does not adversely affect outcomes, provided

184 HIV status does not correlate with the degree or composi

185 HIV testing services increased knowledge of HIV status, driven by an effect among men.

186 0% of all individuals with HIV knowing their HIV status, especially among men and youth.

187 Of these, 117 711 (89.2%) had their HIV status established, of whom 11 964 (10.2%) were HIV

188 During the iPrEx study, there were 51,260 HIV status evaluations among 2,499 volunteers using RTs:

189 ce could not be detected when stratifying by HIV status for either sample type.

190 either HIV-positive MSM or MSM regardless of HIV status, for age bands 16-25, 16-30, 16-35, and 16-40

191 ntly modifies the disposition of SP, whereas HIV status has little influence on pharmacokinetic param

192 on were age </= 50 years, male sex, positive HIV status, history of hemophilia, sickle cell anemia or

193 severe disease (2.47, 1.17-5.24, p=0.0181), HIV status (HIV infected 10.3, 3.26-32.51; HIV exposed,

194 iRBC sequestration (Seqhi, Seqlo, Seq0) and HIV status (HIV+ or HIV-).RESULTSWe identified effector

195 rongly associated with reported male-partner HIV status (HIV-positive 67%, -negative 39%, unknown 31%

196 dently associated with reported male-partner HIV status (HIV-positive 94%, unknown 35%, HIV-negative

197 targeted at all pregnant women regardless of HIV status: (i) conducting home visits to identify pregn

198 nd an association between OPRM1 variants and HIV status in African Americans and whites.

199 teractions were observed between frailty and HIV status in all analyses.

200 cidence is unacceptably high irrespective of HIV status in black Africans.

201 The small observed differences by HIV status in matching characteristics (ie, age and sex)

202 e as a confirmation test provided conclusive HIV status in only 50.0% (CI, 30.8% to 69.2%) of patient

203 BT could substantially increase awareness of HIV status in previously undiagnosed individuals in sub-

204 nmol/L and performed stratified analyses by HIV status in the IPD meta-analysis.

205 on between rectovaginal GBS colonization and HIV status in women.

206 or an unknown human immunodeficiency virus (HIV) status in an HIV-endemic setting.

207 erved changes in IPD incidence, according to HIV status, in children aged 3 months-5 years and in wom

208 The proportion of children with known HIV status increased from 13% in 2005 to 95% in 2012.

209 ates that after acute myocardial infarction, HIV status influences long-term risk, although the short

210 orate auxiliary information on self-reported HIV status into analyses based on partially observed HIV

211 ent treatment strategy for SAM regardless of HIV status involves a high-fat therapeutic diet.

212 HIV status is predictive of cognition and interacts with

213 HIV status is statistically significantly associated wit

214 present in labor who are untested and whose HIV status is unknown.

215 se who present in labor or at delivery whose HIV status is unknown.

216 igated whether human immunodeficiency virus (HIV) status is independently associated with elevated Fe

217 criteria that preclude organ donation, only HIV+ status is singled out as a mandated exclusion to do

218 population stages (first positive HIV test, HIV status knowledge, and linkage to care) and three cli

219 ptible adolescents and adults, regardless of HIV status, may require targeted vaccination efforts to

220 rs for AR to INJ SLDs included age, positive HIV status, MDR tuberculosis and initial treatment with

221 infant CMV acquisition independent of infant HIV status (multivariable hazard ratio, 1.61; 95% confid

222 edictors: having a male partner with unknown HIV status, number of lifetime sexual partners, syphilis

223 tors including human immunodeficiency virus (HIV) status (odds ratio [OR], 7.90; P < .001), and basel

224 n, having anal sex in the past 3 months, and HIV status of 0.60 (95% CI, .33-1.08; P = .086).

225 The HIV status of all women was determined by an immunoglobu

226 was no longer significant when adjusted for HIV status of partner), HIV status (aOR 11.22, 4.05-31.0

227 6-0.85]; p=0.0001 vs 2-5 years), and unknown HIV status of the mother (aOR 0.81 [0.68-0.98], p=0.027

228 Sensitivity analyses of the true HIV status of unconfirmed cases and test sensitivity res

229 association between neonatal GBS disease and HIV-status of the mother and studies that assessed the a

230 in Nairobi, Kenya, to examine the impact of HIV status on (1) introducing influenza to the home and

231 tely deficient (P <.001) but not relative to HIV status or BMD.

232 -points performed similarly, irrespective of HIV status or CD4 count.

233 -1) that were not confounded by immigration, HIV status or drug resistance.

234 nfluencing adherence were: non-disclosure of HIV status (OR = 17.99, p = 0.014); alcohol use (OR = 12

235 , with community structure also differing by HIV status (P = .002, R2 = 0.02).

236 ference in COVID-19 severity on admission by HIV status (P = .15).

237 r cumulative incidence of death over time by HIV status (P = .94).

238 (p=0.001), proportion of women (p=0.01), and HIV status (p=0.03) were noted between the 14 prevalent

239 In multivariate analysis including maternal HIV status, placental malaria, and antibody responses, H

240 es in the levels of morbidity compression by HIV status, PLHIV-especially women living with HIV-spent

241 e majority (78%) of patients felt that their HIV status reduced their chance of LDKT.

242 ected sex with a partner of negative/unknown HIV status) reported 12 months after inclusion between p

243 (regardless of human immunodeficiency virus [HIV] status) seen in a uveitis referral center between 1

244 infant pneumococcal acquisition by maternal HIV status, serotype-specific household exposure, and ot

245 activity was also found to be independent of HIV status, sex, age, KSHV Ab titer, and KSHV-neutralizi

246 prevalence varied significantly (P < .05) by HIV status, sexual orientation, and lifetime number of s

247 Our study suggests that HIV status, sexual risk category, and gender impact gut

248 These data suggest that HIV status should not affect therapeutic decision making

249 inomyces and Streptobacillus interacted with HIV status, such that they were increased in HIV+ MA use

250 a clear difference in response depending on HIV status, suggesting that EE with superimposed HIV ent

251 Based on HIV status, testing history, and the results of an assay

252 hat 90% of people living with HIV know their HIV status, that 90% of those who know their HIV-positiv

253 in HIV-positive couples, and irrespective of HIV status, the majority of couples exhibit HPV concorda

254 ion-based data from ~22,000 persons of known HIV status to characterize migratory patterns and their

255 and partners commonly do not disclose their HIV status to each other.

256 In addition, VL+ YMSM who disclosed their HIV status to sex partners were more likely to report CA

257 hirty-three percent of youth disclosed their HIV status to their first sexual partner.

258 HIV status, travel history, and antimicrobial use data w

259 clinical characteristics, laboratory values, HIV status, treatment, and outcomes from this group and

260 lood pressure, human immunodeficiency virus (HIV) status, urine albumin-to-creatinine ratio, hemoglob

261 mpared inflammatory marker concentrations by HIV status using the Wilcoxon rank-sum test.

262 hange 2 months after treatment initiation by HIV status, using quantile regression, and unsuccessful

263 nificant predictor of Corsi performance, and HIV status was a significant predictor of BCST performan

264 Knowledge of HIV status was ascertained through a caregiver questionn

265 HIV status was ascertained through medical records or HI

266 HIV status was ascertained through medical records or HI

267 HIV status was assessed by enzyme-linked immunosorbant a

268 HIV status was assessed prospectively in hospitalized pa

269 HIV status was associated with a decrease in measures of

270 However, in stratified analysis, HIV status was associated with decreased alpha-diversity

271 In humans, HIV status was associated with significant impairments i

272 Laboratory-confirmed HIV status was available for 19 330 respondents in Zambi

273 The child's HIV status was determined and measles immunoglobulin G (

274 HIV status was established after randomisation.

275 HIV status was ever ascertained for a total of 8,233/9,9

276 Among men, knowledge of HIV status was higher in the HIV self-testing group than

277 Follow-up for HIV status was incomplete for 240 (8.6%) participants.

278 HIV status was independently associated with elevated Fe

279 Following participation, HIV status was known by 90% of men and women in Zambia a

280 for incarceration, residence, and geography, HIV status was no longer significantly associated with c

281 Maternal HIV status was not associated with any outcomes in the o

282 A significant interaction by HIV status was observed for the relation of total SAT wi

283 lative rate of CVD mortality associated with HIV status was significantly higher among women (adjuste

284 lative rate of CVD mortality associated with HIV status was significantly higher among women (adjuste

285 s with one or more survey participants whose HIV status was unknown were eligible to participate in t

286 ermine whether human immunodeficiency virus (HIV) status was independently associated with larger per

287 tients in whom human immunodeficiency virus (HIV) status was known, 38% of those with pregnancy-assoc

288 sex, outcome, Glasgow Coma Scale [GCS], and HIV status) was ascertained at selected sites.

289 Associations between FeNO and HIV status were adjusted for known potential confounders

290 ular carcinoma (HCC), and death according to HIV status were calculated by a Fine-Gray model adjusted

291 es in mean age at, and risk of, diagnosis by HIV status were estimated using multivariate linear regr

292 the levels of blood lipids and biomarkers by HIV status were examined before and after adjustment for

293 n outcomes and human immunodeficiency virus (HIV) statuses were available from 26 sentinel hospital s

294 tic regression adjusting for child age, sex, HIV status, whether the child had been hospitalized in t

295 but 60 of 118 (50.8%) of the women of known HIV status who died during pregnancy or post partum were

296 We determined associations of HIV status with CVD mortality by sex after accounting fo

297 We determined associations of HIV status with CVD mortality by sex and neighborhood po

298 eriolar and venular diameters in relation to HIV status, with a tendency towards narrower retinal dia

299 es limited to women and MSW, controlling for HIV status, women displayed increased alpha-diversity co

300 Interestingly, regardless of HIV status, younger MSM had significantly lower BMD than